Previous Article | Next Article 
Infection and Immunity, May 2001, p. 3389-3397, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3389-3397.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Isogenic Serotypes of Borrelia turicatae
Show Different Localization in the Brain and Skin of Mice
Diego
Cadavid,1,2,3,*
Andrew R.
Pachner,1,3
Lydia
Estanislao,1
Ramaprasad
Patalapati,1 and
Alan
G.
Barbour4
Department of Neuroscience, University of
Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark,
New Jersey 071031; Department of
Neuropathology, Armed Forces Institute of Pathology, Washington, D.C.
203062; Department of Neurology,
Georgetown University Medical Center, Washington, D.C.
200073; and Departments of Microbiology
& Molecular Genetics and Medicine, University of California Irvine,
Irvine, California 926974
Received 27 December 2000/Returned for modification 24 January
2001/Accepted 12 February 2001
 |
ABSTRACT |
Mice with severe combined immunodeficiency (scid mice)
and infected with the relapsing fever agent Borrelia
turicatae develop manifestations that resemble those of
disseminated Lyme disease. We have characterized two isogenic
serotypes, A and B, which differ in their variable small proteins
(Vsps) and disease manifestations. Serotype A but not serotype B was
cultured from the brain during early infection, and serotype B caused
more severe arthritis, myocarditis, and vestibular dysfunction than
serotype A. Here we compared the localization and number of spirochetes
and the severity of inflammation in scid mice, using
immunostained and hematoxylin-and-eosin-stained coronal sections of
decalcified heads. Spirochetes in the brain localized predominantly to
the leptomeninges, and those in peripheral tissues localized mainly to
the extracellular matrix. There were significantly more serotype A than
B spirochetes in the leptomeninges and more serotype B than A
spirochetes in the skin. The first tissue where spirochetes were
observed outside the vasculature was the dura mater. Inflammation was
more severe in the skin than in the brain. VspA, VspB, and the
periplasmic flagellin protein were expressed in all tissues examined.
These findings indicate that isogenic but antigenically distinct
Borrelia serotypes can have marked differences in their localization in tissues.
 |
INTRODUCTION |
Relapsing fever is a disease of
humans caused by several species of the genus Borrelia
(3). During infection there may be several febrile periods
and spirochetemia separated by periods of well-being. The disease is
also notable for involvement of the nervous system; manifestations
include encephalitis, meningitis, peripheral and cranial neuritis,
myelitis, and neuropsychiatric disturbances (9). These
bacteria persist in the host through antigenic variation of single
surface lipoproteins of two types: variable small proteins (Vsps) of
about 23 kDa, and variable large proteins (Vlps) of about 38 kDa. We
found that mice with severe combined immunodeficiency (scid
mice) infected with Borrelia turicatae, the agent of
tick-borne relapsing fever in southwestern North America, develop
manifestations that resemble those of disseminated Lyme disease
(14). Two serotypes, A and B, differed in the Vsps they
expressed and the disease they produced in mice. Overall, serotype B
was more virulent than serotype A; it killed infant mice and caused
severe arthritis, myocarditis, and vestibular dysfunction (14,
33). Serotype A, on the other hand, was more neurotropic: it
infected the brain early in the infection, even though its density in
the blood was 10-fold lower than that of serotype B.
Serotype A is defined by the expression of VspA, and serotype B is
defined by the expression of VspB. The silent and expressed genes for
VspA and VspB have been cloned and characterized (13, 33).
VspA and VspB are part of a larger family of proteins that includes the
Vsps of Borrelia hermsii and the OspCs of the Lyme disease
spirochetes B. burgdorferi, B. afzelii, and
B. garinii. The sequence of the B. turicatae vsp
promoter downstream of the
35 element is highly similar to that of
the OspC promoter of B. burgdorferi. VspA and VspB are
antigenically distinct and differ at 40% of their residues, the
greatest diversity being in their C-terminal halves. VspA shows higher
hydrophobicity than VspB (13), and VspB exhibits an
exceptionally basic pI (33). The expressed loci for
vspA and vspB are located near the center of linear plasmids and are identical to their archival counterparts from
the vsp itself to at least 13 to 14 kb downstream
(34).
The greater arthritogenicity and overall greater virulence of serotype
B appear to be the consequence of 10-fold-higher levels of serotype B
spirochetes in the blood and joints than those for serotype A
infections (32, 33). Less understood is the neurotropism of serotype A cells. Investigation of the localization of serotype A
and B cells in the brain and surrounding tissues during early infection
may provide a basis for understanding the invasion of the brain by
spirochetes. As an initial step toward this goal, we compared the
localization of spirochetes using light microscopy of immunostained
coronal sections of decalcified heads. The results indicate that
isogenic but antigenically distinct serotypes can show marked
differences in their localization during infection.
 |
MATERIALS AND METHODS |
Strains and culture conditions.
B. turicatae was
isolated by injecting Swiss mice with tissues from Ornithodoros
turicata collected in a cave near Ozona, Tex. (14).
Serotypes A and B have been previously described (13, 14,
33). Borrelias were cultured in BSK II medium with 12% rabbit
serum (2) and counted in a Petroff-Hausser chamber under
phase-contrast microscopy (41). When tissue samples were cultured, rifampin (50 µg/ml) and phosphomycin (100 µg/ml) were present in the medium. Plasma samples from infected mice were either
frozen with 10% dimethyl sulfoxide at
80°C or used to start broth
cultures, which at cell densities of 108 per ml were
aliquoted and similarly frozen until use. The purity of the populations
was assessed before infection by Western blotting with
serotype-specific monoclonal antibodies (13, 33).
Protein analysis.
Whole cells from harvested cultures were
subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) with 12.5% acrylamide (5). For
Western blot analysis, proteins were transferred to nitrocellulose
membranes (Millipore), which were then blocked with 3% (wt/vol) dried
nonfat milk in 10 mM Tris (pH 7.4)-150 mM NaCl (milk/TS) for 4 h
(37). After the membranes were washed three times with
0.3% milk/TS, they were incubated with polyclonal antisera diluted
1:50,000 in 0.3% milk/TS. Alkaline phosphatase-conjugated anti-rabbit
antibody (Pierce) served as the second ligand. The blots were developed
with nitroblue tetrazolium chloride-5-bromo
4-chloro-3-indolylphosphatase p-toluidine salt as the
substrate (Pierce).
Mouse infections.
Four- to six-week-old female CB-17
scid mice (Charles River Laboratories, Houston, Tex.) were
inoculated intraperitoneally with 103 borrelia suspensions
in 300 µl of phosphate-buffered saline (PBS). Animals sham inoculated
with PBS were used as controls. The housing and care of animals were in
accordance with the Animal Welfare Act and federal guidelines
(27a) in facilities accredited by the American Association
for Accreditation of Laboratory Animal Care. For evaluation of
spirochetemia, tail vein blood was mixed with an equal volume of PBS
and examined by dark-field microscopy. scid mice were
maintained in a germ-free environment before and after infection.
Tissue and fluid collection.
Mice were anesthetized with
methoxyflurane for euthanasia. Sodium citrate was used as anticoagulant
for exanguination by heart puncture. Total-body perfusion with 30 ml of
PBS was performed as described previously (10), followed
by a second perfusion with 30 ml of 4% paraformaldehyde. The seven
mice used to culture blood and brain were not perfused with
paraformaldehyde. For brain cultures, after the skull was opened under
sterile conditions, brain tissue was removed and rinsed three times
with 1 ml of PBS in sterile 2-ml microcentrifuge tubes (Sarstedt,
Newton, N.C.) (14). To the brain tissue sample was added
twice its volume of BSK II medium. With plungers of sterile 1-ml
plastic syringes (Becton Dickinson, Rutherford, N.J.), the brain tissue
was homogenized in the tubes and then suspended in BSK II medium by
briefly vortexing. Blood and brain suspensions were centrifuged for
5 s at 7,000 × g prior to inoculation into
culture tubes. All cultures were examined for a 2-week period.
Histopathological studies.
The head and spinal cord were
removed after the skin was peeled off at necropsy. The tissues were
fixed in 4% paraformaldehyde for 48 h at 4°C and then
decalcified in 20% EDTA in PBS (pH 7.4) for 3 weeks. The EDTA solution
was changed weekly. The heads were divided in four coronal sections and
embedded in paraffin. The spinal cords were divided in four axial
sections and also embedded in paraffin. Paraffin-embedded sections were
sectioned at 5 µm. Hematoxylin-and-eosin (H&E)-stained slides were
prepared by standard technique. All tissue sections were examined with
standard light microscopy by a neuropathologist masked to the
infectious status. The spirochetal load was measured after
immunostaining (see below) by counting the total number of spirochetes
in each of 10 400× and five 200× consecutive paraffin sections in the
head and spinal cord, respectively. Spirochetes were defined by their
characteristic spiral morphology and positive staining with the
chromogen 3,3-diaminobenzidine tetrahydrochloride. Inflammation was
defined by the characteristic morphology of mononuclear inflammatory
cells on H&E staining. Ten and five 200× microscopic fields were
scored per tissue per mouse in the head and spinal cord, respectively,
as follows: 0, no inflammation; 1, single infiltrate; 2, small
multifocal infiltrates; 3, large multifocal infiltrates; 4, confluent
multifocal infiltrate; or 5, diffuse inflammation.
Immunohistochemistry.
Precleaned superfrost glass slides
(Fisher Scientific) were used for immunohistochemistry. A three-step
streptavidin-peroxidase technique was used to determine the
localization of spirochetes in tissues. All reactions were performed at
room temperature manually or in an automatic immunostainer (Biogenex,
San Ramon, Calif.). Nonspecific binding was reduced by blocking slides
with Biogenex blocking solution for 15 min. Endogenous peroxidase
activity was reduced by incubation with 3%
H2O2 for 20 min at room temperature. Formalin-fixed sections were treated with protease type VIII (0.5 mg/ml; Sigma P-5380) for 10 min for antigen retrieval. A
1:103 dilution of hyperimmune rabbit serum from rabbit
infected with B. burgdorferi strain N40Br was used for
detection of borrelias (11, 28). This hyperimmune serum
has high titers of anti-B. burgdorferi antibodies by
enzyme-linked immunosorbent assay (ELISA) and Western blotting and
cross-reacts with relapsing fever Borrelia spp. (not shown).
Rabbit polyclonal antibody anti-recombinant VspA and VspB at a 1/10,000
dilution were used for detection of expression of VspA and VspB in
tissues (43). Preliminary studies indicated that these
polyclonal antibodies were specific at dilutions
1/10,000 but were
cross-reactive at lower dilutions. Commercially available rat
monoclonal antibody anti-mouse macrophages (F4/80; Serotec, Kidlington,
United Kingdom) at a 1/1,000 dilution was used for identification of
monocytes. For the localization of flagellin, we used mouse monoclonal
antibody H9724 (4). The secondary reagent was a
biotinylated goat anti-rabbit, goat anti-mouse, or rat anti-mouse
polyclonal antibody (Biogenex). The tertiary reagent was horseradish
peroxidase-labeled streptavidin (Biogenex). Incubation times were 30 min for the primary antibody and 20 min for the secondary and tertiary
reagents. The chromogen was 3,3-diaminobenzidine tetrahydrochloride in
0.24% H2O2 for 5 to 15 min. The counterstain was Mayer's hematoxylin for 1 min. In some experiments, the
counterstain was not used to facilitate visualization of spirochetes.
Each incubation was separated by three washes with OptiMax wash buffer (Biogenex). Tissue sections from uninfected animals were used as
negative controls.
Statistical analysis.
Results are given as mean (95%
confidence interval of the mean). Nonparametric tests (Mann-Whitney
Test) were used to determine whether the differences in mean number of
spirochetes between tissues was significant. Chi-square analysis was
used to assess the difference in the proportions of tissues where
spirochetes were observed.
 |
RESULTS |
Infection of blood and brain.
Our goal was to compare the
localization of spirochetes in the nervous system and other tissues of
scid mice infected with neurotropic and nonneurotropic
serotypes of B. turicatae. For this, scid mice
were inoculated intraperitoneally with 103 cells of
serotype A (n = 9) or serotype B (n = 10) of B. turicatae and sacrificed 6 (n = 4), 18 (n = 5 for serotype A and 6 for serotype B), and 40 (n = 4) days later. Four additional mice
were sham inoculated with PBS and sacrificed 6 (n = 2)
and 40 (n = 2) days after inoculation as controls.
Spirochetemia was confirmed prior to necropsy by dark-field examination
of tail vein blood (not shown). In previous studies, serotype A but not
serotype B could be cultured from the brain at 4, 8, and 11 days after
inoculation (14). To extend this observation, we examined
plasma and brain infection by culture in three serotype A-inoculated
and four serotype B-inoculated mice at day 18. The results showed
plasma infection in three of three mice inoculated with serotype A and
four of four mice inoculated with serotype B but brain infection only in the mice inoculated with serotype A. The serotypes present in plasma
and brain were characterized by electrophoresis of whole-cell lysates
of cultured spirochetes (Fig. 1, left
panels). SDS-PAGE showed that a single serotype with a Vsp of the same
size of that of serotype A (23 kDa) was present in plasma and brain
cultures from all serotype A-inoculated mice; similarly, a single
serotype with a Vsp of the same size of that of VspB (20 kDa) was
present in all plasma cultures from serotype B inoculated mice (Fig.
1). To confirm the identity of these serotypes, whole-cell lysates of
cultured spirochetes were examined by Western blotting with rabbit
polyclonal antibodies to recombinant VspA and VspB at 1/50,000 dilution. The results confirmed that the serotypes present in plasma
and/or brain cultures were serotype A or B (Fig. 1, right panels).

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 1.
Left panels, Coomassie blue-stained proteins in
whole-cell lysates of plasma (P) and brain (B) cultures from
scid mice inoculated with serotype A (n = 3)
(top) or serotype B (n = 4) (bottom) of B. turicatae and sacrificed 18 days later. Whole-cell lysates of
serotype A (BtA) and serotype B (BtB) cells are shown to the right for
comparison. The migration of the following molecular weight markers
(WM) are shown to the left (in descending order): 200,000, 116,000, 66,000, 45,000, 31,000, and 21,000. Right panels, whole-cell lysates of
the same P and B cultures and control BtA and BtB lysates, transferred
to nitrocellulose membranes and probed with rabbit polyclonal antibody
to recombinant VspA (top) and VspB (bottom) at a 1/50,000 dilution.
|
|
Localization of spirochetes in tissues.
We next sought to
study the localization of spirochetes in the brain and other tissues
from mice infected with serotype A or B. For this, we used coronal
sections of whole-decalcified heads at the level of the pituitary gland
and the inner ear, immunostained with a rabbit polyclonal antibody to
Borrelia spp. Multiple sections from two mice each
inoculated with serotype A or serotype B and sacrificed 6, 18, and 40 days after inoculation were first examined by light microscopy for the
presence of spirochetes. Spirochetes were found in several tissues at
days 18 and 40 after inoculation. In the brain, the localization was
primarily leptomeningeal (Fig. 2A),
although rare spirochetes were also found in the brain parenchyma (Fig.
2C). The spirochetes were not limited to the central nervous system.
They were also present in the dura mater in the convexity (Fig. 2B) and
at the base of the brain, in the middle and inner (Fig. 2E and F) ear,
in the endoneurium, in the skin, and in the bone marrow. Clumps of
spirochetes were observed only in the subarachnoid space, inner ear
(Fig. 2E), and skin (Fig. 3B).
Spirochetes were also found in the extracellular matrix of skeletal and
cardiac muscle and in peripheral and cranial nerves, notably the VII
(facial) cranial nerve (Fig. 2D). No spirochetes were found in salivary glands. Intravascular spirochetes and red blood cells were infrequent, confirming that exanguination and perfusion were adequate. No spirochetes were seen in any of the PBS-inoculated controls.

View larger version (116K):
[in this window]
[in a new window]
|
FIG. 2.
B. turicatae in the leptomeninges (A;
magnification, ×900), dura mater (B; ×900), brain parenchyma (C;
×750), peripheral facial (VII) nerve (D; ×750), and cochlea next to
the origin of the auditory nerve (E; ×500) and in a semicircular canal
at the origin of the vestibular nerve (E; ×900) in scid
mice 40 days after inoculation (immunohistochemistry with
anti-Borrelia polyclonal antibody).
|
|

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 3.
Immunostaining for Vsp in skin from scid mice
infected with B. turicatae serotypes A (A; anti-VspA rabbit
polyclonal antibody; magnification, ×750), serotype B (B; anti-VspB
rabbit polyclonal antibody; ×750), and PBS as a control (C; anti-VspB
rabbit polyclonal antibody; ×400).
|
|
We next determined the number of spirochetes in 20 consecutive 400×
microscopic fields of different tissues of mice infected
with serotype
A or B at days 6, 18, and 40 after inoculation (Table
1). Rare spirochetes were seen in the
brain parenchyma, leptomeninges,
dura mater, and skin 6 days after
inoculation. The numbers were
higher in the dura mater at day 6. Eighteen days after inoculation,
the number of spirochetes was
significantly higher in the leptomeninges
for serotype A-infected than
for serotype B-infected mice and
significantly higher in the skin for
serotype B-infected than
for serotype A-infected mice. The tissues with
the highest and
lowest spirochetal numbers 18 days after inoculation
were the
skin and the brain parenchyma, respectively. Forty days after
inoculation, there were still about four times as many serotype
A as
serotype B spirochetes in the leptomeninges, while there
was not a
statistical difference between serotype A- and B-infected
mice in the
numbers of the spirochetes in the skin. There was
no significant
difference in the number of spirochetes in the
dura mater at any time.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Number of spirochetes in tissues of scid mice
examined 6, 18, and 40 days after inoculation with B. turicatae serotype A or serotype B or PBS as a control
|
|
Characterization of early infection.
The previous results
suggested that the largest number of spirochetes in tissues during
early infection was found in the dura mater. To further investigate
this, we infected new groups of scid mice with serotype A
(n = 5) or serotype B (n = 5) and
sacrificed them 3 (n = 2 each) and 4 (n = 3 each) days later. Several coronal sections from
whole-decalcified heads immunostained with anti-Borrelia antibody were examined for the presence of spirochetes in the bone
marrow, skin, dura mater, leptomeninges, and brain parenchyma. The
results showed spirochetes present in the bone marrow and dura mater in
9 of 10 and 8 of 10 mice, respectively, compared with spirochetes in
the skin and the brain (leptomeninges and parenchyma) in 1 of 10 and
none of 10 mice, respectively. There were more spirochetes in the dura
mater than in the bone marrow in all mice. These results indicated that
the dura mater was the first tissue in the head where spirochetes
disseminate from the blood.
Expression of spirochetal proteins in tissues.
To determine if
the variable surface proteins of serotype A (VspA) and serotype B
(VspB) and the flagellar protein of Borrelia spp.
(flagellin) were expressed by spirochetes in the nervous system and
other tissues, we studied coronal sections from whole-decalcified heads
by immunohistochemistry with antibodies to VspA, VspB, and flagellin.
The results showed expression of VspA by spirochetes in all tissues
examined from serotype A-inoculated mice and of VspB in all tissues
examined from serotype B-inoculated mice (Fig. 3). Flagellin was
expressed in all tissues examined (not shown).
Inflammatory response to the infection.
We compared the
presence and severity of inflammation in infected tissues from serotype
A- and B-inoculated mice and uninfected controls using light microscopy
of H&E-stained paraffin sections. For this, the severity of
inflammation was scored from 0 to 5 in 10 consecutive 200× microscopic
fields (Table 2). No inflammation was
found in the meninges or skin during early infection. At days 18 and 40 after inoculation, there was severe inflammation in the skin of mice
infected with either serotype (Fig. 4B).
Minimal although significant inflammation was also found in the
meninges at days 18 and 40, with no significant differences between the two serotypes. Examination with H&E staining revealed that the inflammatory infiltrate in the skin was mainly mononuclear.
Immunostaining of the skin revealed that the majority of the
inflammatory cells were macrophages (Fig. 4C).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Severity of inflammation over time in different tissues
from scid mice infected with serotype A or B of B. turicatae or PBS as a control
|
|

View larger version (112K):
[in this window]
[in a new window]
|
FIG. 4.
Inflammation in scid mice 40 days after
inoculation of B. turicatae. (A and B) Mononuclear
inflammatory exudate in the middle ear (A; magnification ×300) and the
skin (B; ×100) of a scid mouse infected with serotype B
(H&E stain). (C and D) Immunostaining for mouse macrophages in the skin
of scid mice inoculated with B. turicatae
serotype B (C; ×800) or PBS as a control (D; ×400; F4/80
antibody and hematoxylin counterstain).
|
|
We had previously found that a peripheral-type vestibular disorder
began 3 to 4 weeks after inoculation and occurs more often
in
scid mice infected with serotype B than serotype A
(
14).
To investigate the etiology of this vestibular
disorder, we examined
H&E-stained coronal sections from decalcified
heads at the level
of the inner ear for the presence of inflammation.
Eight mice
infected with serotype A (
n = 4) or serotype
B (
n = 4) and sacrificed
at 18 (
n = 2
each) and 40 (
n = 2 each) days after inoculation
were
examined. Inflammation in both the middle and inner ear was
observed in
all cases; the greatest amount of exudate was in the
mucosa of the
middle ear (Fig.
4A). At day 40 after inoculation,
the number of
spirochetes was significantly higher in the inner
(Fig.
2E) than in the
middle ear with both serotypes: the mean
(95% confidence interval of
the mean) numbers of spirochetes in
the middle and inner ear,
respectively, were 0.5 (0.06 to 0.9)
and 5.96 (3.4 to 8.5) for serotype
A, 0.12 (0 to 0.24) and 7.5
(3.6 to 11.4) for serotype B, and 0 and 0 for uninfected controls.
In contrast, no spirochetes or inflammation
were observed in the
cerebellum or brainstem. These experiments
revealed that the vestibular
disorder was caused by infection and
inflammation of the vestibular
apparatus in the inner ear
(laberynthitis).
Infection of the spinal cord.
To determine if the differences
found in the brain of scid mice infected with serotype A or
B also occurred in the spinal cord, a different examiner counted the
number of spirochetes and estimated the severity of inflammation in
five 200× microscopic fields at various levels of the spinal cord
(Table 3). The mean (95% confidence
interval) number of spirochetes during early infection was very low in
all mice examined. The mean number of spirochetes at day 18 was
significantly higher in the skin of serotype B than serotype A-infected
mice, as was the case for the head. Meningeal inflammation was also
mild in both groups. In contrast, the number of leptomeningeal
spirochetes in the spinal cord was very low in both serotype A- and
serotype B-infected mice. Also different from the heads was the finding
of mild inflammation in the skin surrounding the spinal cord during
early infection.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Infection of the spinal cord in scid mice
inoculated with serotype A or B of B. turicatae at various
times after inoculationa
|
|
 |
DISCUSSION |
Switching between serotypes provides relapsing fever borrelias
with a strategy not only to avoid the host's antibody response but
also to exploit different microenvironments, including the brain. For
further insight into the mechanism responsible for brain infection by
Borrelia spp., we compared the localization of two serotypes
of B. turicatae in the brain and other tissues of
scid mice. For this, we examined coronal sections of
whole-decalcified heads by immunohistochemistry and used H&E-stained
sections to compare the inflammatory response to the infection. The
major findings were the following: (i) the localization of spirochetes in the brain and spinal cord was primarily leptomeningeal; (ii) there
were significantly more serotype A than serotype B cells in the
leptomeninges 18 and 40 days after inoculation; (iii) there were
significantly more serotype B than serotype A cells in the skin 18 but
not 40 days after inoculation; (iv) The tissue with the most severe
inflammation was the skin; (v) the dura mater was the first tissue
where spirochetes were observed outside of the vasculature; and (vi)
the predominant surface lipoproteins VspA and VspB and the periplasmic
protein flagellin were expressed at all times in all tissues examined.
Prior studies using cultured brains had demonstrated that serotype A
but not serotype B was present in the brain of scid mice 4, 8, and 11 days after inoculation (14). The present study extends this observation to 18 days after inoculation. The localization of serotype A cells in the brain primarily to the leptomeninges was
expected. Meningitis is a prominent clinical manifestation of
neuroborreliosis in tick-borne relapsing fever and Lyme disease (9, 29). The presence of relapsing fever spirochetes in
the brain of experimental animals was known as early as 1922 (7). We knew from our own studies of infection of
irradiated mice with B. hermsii that spirochetes cross the
blood-brain barrier and are not merely present in the intravascular
space of the brain (10). Using nonspecific silver
impregnation techniques, the pioneers in the field observed relapsing
fever borrelias in the gray matter between neurons and glias
(7) and within cerebral capillaries, leptomeningeal
vessels, and choroid plexus (24). Relapsing fever
borrelias from Africa were observed more commonly in the medulla and
deeper parts of the brain than in the cortex of mice and rats
(38, 40). The localization was extracellular (20). We were surprised by the small number of spirochetes
found in the brain parenchyma compared with the leptomeninges
(21). It is possible that examination of brains infected
for longer periods of time will reveal increasing localization of
borrelias to the brain parenchyma. We confirmed that all spirochetes
found in tissues from serotype A- or B-infected mice expressed VspA or
VspB, respectively. In a prior study, we showed that VspB is expressed
by spirochetes in the blood, joints, and heart of mice (33). Expression of flagellin in infected tissues has been
demonstrated in the nonhuman primate model of Lyme disease
(11). Down regulation of major surface proteins during
infection, known to occur with B. burgdorferi (11,
16), was not observed in these studies.
The localization of spirochetes in the brain has been studied in other
spirochetal diseases. In the nonhuman primate model of Lyme disease,
spirochetes were found in the leptomeninges, nerve roots, dorsal root
ganglia, endoneurium, and extracellular matrix of peripheral nerves,
skeletal muscle, heart, and bladder in immunosuppressed animals
(11). In contrast, no spirochetes were found in tissues
from immunocompetent animals, even those positive by PCR-ELISA
(11, 36). B. burgdorferi has been reported intracellularly in vitro in human umbilical vein endothelial cells (22) and macrophages (26) but not in vivo
(11). In neurosyphilis, Treponema pallidum was
found in the cortex of 25 to 40% of paretic brains examined at
autopsy, mainly in the frontal areas, and is difficult to find after
treatment (12). In untreated syphilitic lesions in the
skin, the majority of treponemes are extracellular (42).
Our studies suggest that borrelias first enter the central nervous
system in the subarachnoid space and localize mainly to the
leptomeninges, with only a few moving to the brain parenchyma early on.
There are two possible routes to reach the subarachnoid space from the
circulation: crossing the microvessels of the leptomeninges, and
crossing the dura mater-arachnoidal barrier. In support of the first
route is the frequent observation of spirochetes located partially in
the microvascular lumen and partially in the subarachnoid space of the
scid mice. In support of the second route is the observation
that the dura mater is the first tissue where spirochetes were found
outside of the vasculature. The reason why serotype A cells move into
the subarachnoid space significantly better than serotype B cells is
unknown. One possibility could be differences in the hydrophobicity of
their Vsps: VspA has higher hydrophobicity than VspB (13),
and VspB has a more basic pI (33). Another possibility is
differences in their binding to glycosaminoglycans or other components
of the extracellular matrix. A recent study found that serotype B cells
bound to glycoaminoglycans significantly better than serotype A cells,
and recombinant VspB but not VspA bound heparin and dermatan sulfate
(23). Other bacteria have been found to have variable
proteins associated with brain infection. These include the outer
membrane protein A of Escherichia coli (25,
35), internalin B of Listeria monocytogenes
(31), and the pili and class 5 outer membrane proteins of
Neisseria meningitidis (27).
The high number of spirochetes in the skin indicates this tissue favors
the multiplication and dissemination of spirochetes. A skin lesion,
erythema migrans, characterizes early Lyme disease (6).
There is no evidence that B. burgdorferi produces
collagenase, elastase, hyaluronidase, or other enzymes that digest
extracellular matrix components. However, both B. burgdorferi and the relapsing fever borrelias have been shown to
bind human plasmin, plasminogen, and urokinase-type plasminogen
activator (15, 19). The binding of plasminogen allows the
formation of a bioactive extracellular matrix protease, which
facilitates their dissemination through the extracellular matrix of
infected tissues (18).
We found only mild inflammation in the meninges of the brain and spinal
cord of infected animals. Early in the infection of rats with B. turicatae, there was severe congestion of leptomeningeal vessels
and parenchymal capillaries, foci of cortical hemorrhages, and intense
microglia reaction in the cerebral and cerebellar cortex and
hippocampus (24). Later in the infection, there was only
lymphocytic infiltration of the leptomeninges. Guinea pigs infected
with B. persica had perivascular hemorrhage and infiltration with lymphocytes and macrophages in the brain (1).
Selective damage to neurons in the upper part of the spinal cord and
posterior columns was found in rats infected with relapsing fever
strains from Russia (8). Leptomeningeal inflammation was
observed only rarely in the nonhuman primate of Lyme disease (11,
30). Two recent studies of mice infected with B. crocidurae (39) and with a relapsing fever
Borrelia from Spain (17, 18) showed meningitis
and brain parenchymal microgliosis. B. crocidurae but not
the relapsing fever Borrelia from Spain were observed in the brain parenchyma.
Starting with syphilis and relapsing fever and continuing with Lyme
disease, spirochetes remain as important neurological pathogens. A
better understanding of the mechanisms by which they cause neurological
disease is needed. Our studies suggest that the proteins present in the
surface of the spirochetes provide a mechanism for differential
localization in tissue during infection. Future studies may elucidate
the mechanisms by which spirochetes enter and persist in the brain and
cause neurological disease.
 |
ACKNOWLEDGMENTS |
This work was supported in part by National Institutes of Health
grant AI24424 to A.G.B. and a National Institute of Mental Health grant
to A.R.P. D.C. was supported by a Méndez Fellowship for
Clinicians from the American Registry of Pathology and by a grant to
the Hispanic Center of Excellence at UMDNJ-New Jersey Medical School
from the Bureau of Health Professions, Health Resources and Services Administration.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Neuroscience, UMDNJ-New Jersey Medical School, Newark, NJ 07103. Phone: (973) 972-8686. Fax: (973) 972-5059. E-mail:
cadavidi{at}umdnj.edu.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Ashbel, R.
1942.
Observations on some strains of Spirochaeta persica in Palestine.
Ann. Trop. Med. Parasitol.
36:97-101.
|
| 2.
|
Barbour, A.
1984.
Isolation and cultivation of Lyme disease spirochetes.
Yale J. Biol. Med.
57:521-525[Medline].
|
| 3.
|
Barbour, A. G., and S. F. Hayes.
1986.
Biology of Borrelia species.
Microbiol Rev.
50:381-400[Free Full Text].
|
| 4.
|
Barbour, A. G.,
S. F. Hayes,
R. A. Heiland,
M. E. Schrumpf, and S. L. Tessier.
1986.
A Borrelia-specific monoclonal antibody binds to a flagellar epitope.
Infect. Immun.
52:549-554[Abstract/Free Full Text].
|
| 5.
|
Barbour, A. G.,
S. L. Tessier, and H. G. Stoenner.
1982.
Variable major proteins of Borrellia hermsii.
J. Exp. Med.
156:1312-1324[Abstract/Free Full Text].
|
| 6.
|
Berger, B. W.
1984.
Erythema chronicum migrans of Lyme disease.
Arch. Dermatol.
120:1017-1021[Abstract/Free Full Text].
|
| 7.
|
Buschke, A., and H. Kroo.
1922.
Experimental recurrentis infection.
Klin. Wochenschr.
1:2470[CrossRef].
|
| 8.
|
Buschke, A., and H. Kroo.
1923.
Spinale strangdegeneration nach experimenteller rekurrens.
Dtsch. Med. Wochenschr.
49:1435-1436.
|
| 9.
|
Cadavid, D., and A. G. Barbour.
1998.
Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals.
Clin. Infect. Dis.
26:151-164[Medline].
|
| 10.
|
Cadavid, D.,
V. Bundoc, and A. G. Barbour.
1993.
Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis.
J. Infect. Dis.
168:143-151[Medline].
|
| 11.
|
Cadavid, D.,
T. O'Neill,
H. Schaefer, and A. Pachner.
2000.
Localization of Borrelia burgdorferi in the nervous system and other tissues in a non-human primate model of Lyme disease.
Lab. Investig.
80:1043-1054[Medline].
|
| 12.
|
Cadavid, D., and A. R. Pachner.
1998.
Neurosyphilis, p. 1-43.
In
R. C. Griggs, and R. J. Joynt (ed.), Clinical neurology. Lippincott-Raven, Philadelphia, Pa.
|
| 13.
|
Cadavid, D.,
P. M. Pennington,
T. A. Kerentseva,
S. Bergstrom, and A. G. Barbour.
1997.
Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae.
Infect. Immun.
65:3352-3360[Abstract].
|
| 14.
|
Cadavid, D.,
D. D. Thomas,
R. Crawley, and A. G. Barbour.
1994.
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis.
J. Exp. Med.
179:631-642[Abstract/Free Full Text].
|
| 15.
|
Coleman, J. L.,
T. J. Sellati,
J. E. Testa,
R. R. Kew,
M. B. Furie, and J. L. Benach.
1995.
Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers.
Infect. Immun.
63:2478-2484[Abstract].
|
| 16.
|
Fikrig, E.,
W. Feng,
J. Aversa,
R. T. Schoen, and R. A. Flavell.
1998.
Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis.
J. Infect. Dis.
178:1198-1201[Medline].
|
| 17.
|
Garcia-Monco, J. C.,
N. S. Miller,
P. B. Backenson,
P. Anda, and J. L. Benach.
1997.
A mouse model of Borrelia meningitis after intradermal injection.
J. Infect. Dis.
175:1243-1245[Medline].
|
| 18.
|
Gebbia, J. A.,
J. C. Monco,
J. L. Degen,
T. H. Bugge, and J. L. Benach.
1999.
The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis.
J. Clin. Investig.
103:81-87[Medline].
|
| 19.
|
Klempner, M. S.,
R. Noring,
M. P. Epstein,
B. McCloud,
R. Hu,
S. A. Limentani, and R. A. Rogers.
1995.
Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi.
J. Infect. Dis.
171:1258-1265[Medline].
|
| 20.
|
Levaditi, C.,
T. Anderson,
F. Selbie, and R. Schoen.
1929.
Presence du spirille de la fievre recurrente (Sp. duttoni) dans le cerveau des animaux immuns.
Bull. Acad. Med.
102:705-710.
|
| 21.
|
Levaditi, J.,
G. Balouet,
B. Juminer, and A. Corcos.
1966.
Borreliose experimentale du raton nouveau-ne. Etude histologique.
Bull. Soc. Pathol. Exot.
59:310-316.
|
| 22.
|
Ma, Y.,
A. Sturrock, and J. J. Weis.
1991.
Intracellular localization of Borrelia burgdorferi within human endothelial cells.
Infect. Immun.
59:671-678[Abstract/Free Full Text].
|
| 23.
|
Magoun, L.,
W. R. Zuckert,
D. Robbins,
N. Parveen,
K. R. Alugupalli,
T. G. Schwan,
A. G. Barbour, and J. M. Leong.
2000.
Variable small protein (Vsp)-dependent and vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes.
Mol. Microbiol.
36(4):886-897[CrossRef][Medline].
|
| 24.
|
Martinez-Baez, M., and A. Villasana.
1945.
Sobre la histopatologia de la fiebre recurrente experimental.
Rev. Inst. Salub. Enferm. Trop.
6:185-194.
|
| 25.
|
Meier, C.,
T. A. Oelschlaeger,
H. Merkert,
T. K. Korhonen, and J. Hacker.
1996.
Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells.
Infect. Immun.
64:2391-2399[Abstract].
|
| 26.
|
Montgomery, R. R.,
M. H. Nathanson, and S. E. Malawista.
1993.
The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery.
J. Immunol.
150:909-915[Abstract].
|
| 27.
|
Nassif, X., and M. So.
1995.
Interaction of pathogenic neisseriae with nonphagocytic cells.
Clin. Microbiol. Rev.
8:376-388[Abstract].
|
| 27a.
|
National Institutes of Health.
1985.
Guide for the care and use of laboratory animals, rev. ed. Department of Health and Human Services publication no. (NIH) 85-23.
National Institutes of Health, Bethesda, Md.
|
| 28.
|
Pachner, A. R.,
S. T. Braswell,
E. Delaney,
K. Amemiya, and E. Major.
1994.
A rabbit model of Lyme neuroborreliosis: characterization by PCR, serology, and sequencing of the OspA gene from the brain.
Neurology
44:1938-1943[Abstract/Free Full Text].
|
| 29.
|
Pachner, A. R., and D. Cadavid.
1998.
Lyme neuroborreliosis, p. 1-19.
In
R. C. Griggs, and R. J. Joynt (ed.), Clinical neurology. Lippincott-Raven, Philadelphia, Pa.
|
| 30.
|
Pachner, A. R.,
E. Delaney,
T. O'Neill, and E. Major.
1995.
Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease.
Neurology
45:165-172[Abstract/Free Full Text].
|
| 31.
|
Parida, S. K.,
E. Domann,
M. Rohde,
S. Muller,
A. Darji,
T. Hain,
J. Wehland, and T. Chakraborty.
1998.
Internalin B is essential for adhesion and mediates the invasion of Listeria monocytogenes into human endothelial cells.
Mol. Microbiol.
28:81-93[CrossRef][Medline].
|
| 32.
|
Pennington, P. M.,
C. D. Allred,
C. S. West,
R. Alvarez, and A. G. Barbour.
1997.
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.
Infect. Immun.
65:285-292[Abstract].
|
| 33.
|
Pennington, P. M.,
D. Cadavid, and A. G. Barbour.
1999.
Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice.
Infect. Immun.
67:4637-4645[Abstract/Free Full Text].
|
| 34.
|
Pennington, P. M.,
D. Cadavid,
J. Bunikis,
S. J. Norris, and A. G. Barbour.
1999.
Extensive interplasmidic duplications change the virulence phenotype of the relapsing fever agent Borrelia turicatae.
Mol. Microbiol.
34:1120-1132[CrossRef][Medline].
|
| 35.
|
Prasadarao, N. V.,
C. A. Wass,
M. F. Stins,
H. Shimada, and K. S. Kim.
1999.
Outer membrane protein A-promoted actin condensation of brain microvascular endothelial cells is required for Escherichia coli invasion.
Infect. Immun.
67:5775-5783[Abstract/Free Full Text].
|
| 36.
|
Roberts, E. D.,
R. P. Bohm, Jr.,
R. C. Lowrie, Jr.,
G. Habicht,
L. Katona,
J. Piesman, and M. T. Philipp.
1998.
Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system.
J. Infect. Dis.
178:722-732[Medline].
|
| 37.
|
Sadziene, A.,
P. A. Rosa,
P. A. Thompson,
D. M. Hogan, and A. G. Barbour.
1992.
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.
J. Exp. Med.
176:799-809[Abstract/Free Full Text].
|
| 38.
|
Schauder, H.
1928.
Zur frage der spirochatenpersistenz in zentralnervensystem und ihrer chemotherapeutischen beeinflussbarkeit bei experimenteller rekurrens.
Arch. Schiffs Trop. Hyg.
32:1-13.
|
| 39.
|
Shamaei-Tousi, A.,
P. Martin,
A. Bergh,
N. Burman,
T. Brannstrom, and S. Bergstrom.
1999.
Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli.
J. Infect. Dis.
180:1929-1938[CrossRef][Medline].
|
| 40.
|
Steiner, G.,
J. Steinfeld, and H. Schauder.
1925.
Zur frage der spirochatenpersistenzim zentralnervensystem bei experimenteller recurrens.
Klin. Wochenschr.
4:2288-2289[CrossRef].
|
| 41.
|
Stoenner, H.,
T. Dodd, and C. Larsen.
1982.
Antigenic variation of Borrelia hermsii.
J. Exp. Med.
156:1297-1311[Abstract/Free Full Text].
|
| 42.
|
Wecke, J.,
J. Bartunek, and G. Stuttgen.
1976.
Treponema pallidum in early syphilitic lesions in humans during high-dosage penicillin therapy. An electron microscopical study.
Arch. Dermatol. Res.
257:1-15[CrossRef][Medline].
|
| 43.
|
Zuckert, W. R.,
J. Meyer, and A. G. Barbour.
1999.
Comparative analysis and immunological characterization of the Borrelia Bdr protein family.
Infect. Immun.
67:3257-3266[Abstract/Free Full Text].
|
Infection and Immunity, May 2001, p. 3389-3397, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3389-3397.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Londono, D., Marques, A., Hornung, R. L., Cadavid, D.
(2008). Relapsing Fever Borreliosis in Interleukin-10-Deficient Mice. Infect. Immun.
76: 5508-5513
[Abstract]
[Full Text]
-
Londono, D., Marques, A., Hornung, R. L., Cadavid, D.
(2008). IL-10 Helps Control Pathogen Load during High-Level Bacteremia. J. Immunol.
181: 2076-2083
[Abstract]
[Full Text]
-
Gelderblom, H., Schmidt, J., Londono, D., Bai, Y., Quandt, J., Hornung, R., Marques, A., Martin, R., Cadavid, D.
(2007). Role of Interleukin 10 during Persistent Infection with the Relapsing Fever Spirochete Borrelia turicatae. Am. J. Pathol.
170: 251-262
[Abstract]
[Full Text]
-
Sethi, N., Sondey, M., Bai, Y., Kim, K. S., Cadavid, D.
(2006). Interaction of a Neurotropic Strain of Borrelia turicatae with the Cerebral Microcirculation System. Infect. Immun.
74: 6408-6418
[Abstract]
[Full Text]
-
Londono, D., Bai, Y., Zuckert, W. R., Gelderblom, H., Cadavid, D.
(2005). Cardiac Apoptosis in Severe Relapsing Fever Borreliosis. Infect. Immun.
73: 7669-7676
[Abstract]
[Full Text]
-
Zuckert, W. R., Lloyd, J. E., Stewart, P. E., Rosa, P. A., Barbour, A. G.
(2004). Cross-Species Surface Display of Functional Spirochetal Lipoproteins by Recombinant Borrelia burgdorferi. Infect. Immun.
72: 1463-1469
[Abstract]
[Full Text]
-
Cadavid, D., Bai, Y., Dail, D., Hurd, M., Narayan, K., Hodzic, E., Barthold, S. W., Pachner, A. R.
(2003). Infection and Inflammation in Skeletal Muscle from Nonhuman Primates Infected with Different Genospecies of the Lyme Disease Spirochete Borrelia burgdorferi. Infect. Immun.
71: 7087-7098
[Abstract]
[Full Text]